Clinical Trial Update: Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and efficacy of NA-931 and tirzepatide in adults who are overweight or obese; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• NA-931
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Biomed Industries, Inc. | Conditions: Obesity and Overweight | Phase 2 | Status: NOT_YET_RECRUITING